Decrease in Sick Leave Among Patients With Rheumatoid Arthritis in the First 12 Months After Start of Treatment With Tumour Necrosis Factor Antagonists: A Population-Based Controlled Cohort Study

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/ard.2009.127852
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Tumor Necrosis Factor Α Antagonists in the Treatment of the Patients With Rheumatoid Arthritis

Reumatologia
RheumatologyAllergyImmunology
2012English

Combined Therapy With Prospidin and Methotrexate in Rheumatoid Arthritis (12 Months Controlled Study)

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2003English

Predictors of Sick Leave and Improved Worker Productivity After 52 Weeks of Intensive Treatment in Patients With Early Rheumatoid Arthritis

Scandinavian Journal of Rheumatology
MedicineRheumatologyAllergyImmunology
2019English

Serious Infections in Rheumatoid Arthritis Offspring Exposed to Tumour Necrosis Factor Α Inhibitors: Cohort Study

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Predictors of Treatment Initiation With Tumor Necrosis Factor-Α Inhibitors in Patients With Rheumatoid Arthritis

Journal of Managed Care Pharmacy
2014English

Healthcare Consultation and Sick Leave Before and After Neck Injury: A Cohort Study With Matched Population-Based References

BMJ Open
Medicine
2013English

Malignancy Risk in Australian Rheumatoid Arthritis Patients Treated With Anti-Tumour Necrosis Factor Therapy: Analysis of the Australian Rheumatology Association Database (ARAD) Prospective Cohort Study

BMC Musculoskeletal Disorders
RheumatologyOrthopedicsSports Medicine
2015English

Circulating Tumour Necrosis Factor Alpha and Soluble Tumour Necrosis Factor Receptors in Patients With Different Patterns of Rheumatoid Synovitis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2003English

The Risk of Acute Coronary Syndrome in Rheumatoid Arthritis in Relation to Tumour Necrosis Factor Inhibitors and the Risk in the General Population: A National Cohort Study

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy